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$EVWUDFW 
Aroma touch therapy is widely used in clinical fields for alleviating pain-related symptoms; however, 
few studies have reported the pain-relief mechanisms. The present study aimed to elucidate the 
analgesic effects of aroma touch therapy with &LWUXVMXQRV oil based on the quantitative evaluation of 
deep brain network (DBN) activity using electroencephalogram (EEG) occipital alpha-2 rhythm (10–
13 Hz) powers. Experimental investigations were performed with 13 healthy volunteers using the cold 
pressor task for simulating chronic pain in three different sessions: a baseline session with no therapies, 
a control session with a touch therapy, and an aroma touch therapy. We found for the first time that the 
interviewed pain ratings represented by Numeric Rating Scale (NRS) scores were strongly correlated 
with a DBN activity index, which was derived from the slow fluctuation components of occipital EEG 
alpha-2 rhythm powers. The correlation was characterized by a V-shaped curve in the DBN activity 
index versus the pain rating, i.e., the NRS score, which provided the complete analgesic states (NRS 
= 0) for some subjects under aroma touch therapy at an appropriate DBN activity index. Such analgesic 
states were not so strongly correlated with emotional valence.  
In conclusion, aroma touch therapy may directly modulate DBN activity so that pain-induced 
outcomes are minimized. 
  
 .H\ZRUGVAroma Touch Therapy; Chronic Pain; Encephalogram Occipital Alpha-2 rhythm; Citrus 
junos (Yuzu) oil 
 
 ,QWURGXFWLRQ
Aromatherapy is a standard method used in complementary and alternative medicine [1–4]. Essential 
oils are utilized in aromatherapy, and they are synthesized from natural volatile organic compounds. 
Aromatherapy is characterized by low side effects [5, 6]. This is of great advantage for clinical 
applications and is supported by a wide variety of practical implementations and evidence for the 
alleviation of symptoms related to higher-order brain dysfunctions, such as dementia [5, 7–9], attention 
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deficit hyperactivity disorders [10], and mood disorders [11–13], as well as for pain control [14, 15], 
stress management, and health promotion [16–18]. Aromatherapy has also been applied to palliative 
care in hospice [19–23], and its validity has been demonstrated not only for maintaining a high quality 
of life (QOL) [24–27] but also for alleviating chronic pain associated with cancer [27]. 
Aromatherapy provides various practical therapies ranging from simple inhalation of an essential 
oil to a complicated aroma massage. Aroma touch is a type of massage, but the use of essential oils 
distinguishes it from original forms defined as “manual soft tissue manipulation including holding, 
causing movement, and/or applying pressure to the body,” according to the American Massage 
Therapy Association [28]. Aroma touch therapy is equivalent to pediatric massage in which only mild 
pressure is applied. Hence, aroma touch therapy is considered safe and effective even for cancer 
patients in hospices [29] and has shown highly efficient effects of alleviating various symptoms 
associated with cancer [30–32]. Based on this assumption, we performed an advance clinical trial to 
examine the effects of aroma touch therapy on a cancer patient [33]. The results revealed that aroma 
touch therapy might improve QOL and reduce pain-related syndromes. Such clinical evidences are 
considered to support the recent increasing demands for aroma touch therapy in hospices.  
Many studies have investigated chronic pain, as a target of aromatherapy, to elucidate neural 
mechanisms. To explain how chronic pain conditions are formed even in the absence of afflicted body 
parts, a concept of the Pain Matrix was proposed by Melzack [34]. This concept integrates pain-related 
cortical regions typically including the somatosensory area, anterior cingulate cortex, insular cortex, 
and medial prefrontal cortex to construct a pain network for pain perception. In the early stage of 
chronic pain studies, much interest was focused on thalamic activity, taking into account the 
anatomical structure that thalamus terminates the spinothalamic tract and transfers pain signals to the 
Pain Matrix [35]. Previous clinical studies utilizing neuroimaging techniques for cerebral regional 
blood flows [36] reported that thalamic activity is significantly decreased under chronic pain 
conditions. They also reported that completely pain-free states in patients with chronic pain can be 
obtained with thalamic stimulation [37–39]. From an electrophysiological view point, chronic pain 
conditions are related to dysfunctions of the thalamus, which are characterized as thalamocortical 
dysrhythmias, and these that can be detected in low-frequency ranges of electroencephalogram (EEG) 
or magnetoencephalogram signals [40–42]. On the basis of these clinical findings, it was assumed that 
the analgesic effects of aroma touch therapy can be attributed to thalamic activation. Hence, we were 
interested in detereming how thalamic activity is changed in pain-free states by aromatherapy.  
The region related to the thalamus and limbic system is also strongly correlated with emotion. 
Hence, the emotional effects of aroma touch therapy on pain ratings must be considered to discuss the 
analgesic effects. According to the Pain Matrix model [43–45], pain sensation represented on the 
cortices can be emotionally modulated independently of thalamic activity. Pleasantness evoked by 
odor and touch reduces pain ratings and even provide pain-free states [46]. Such analgesic effects of 
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aroma touch therapy are even considered as placebo effects given by higher-order brain functions [47–
49]. Therefore, we were interested in detereming whether thalamic activity or emotion changes are 
dominant.  
The present study aimed to clarify the two issues of interest as mentioned above: the quantitative 
evaluation of thalamic activity under analgesic states and determination of a dominant factor from the 
two candidates of thalamic activity and emotional modulation evoked by aroma touch therapy. We 
therefore performed both neurophysiological and neuropsychological investigations on the analgesic 
effects of aroma touch therapy in healthy subjects who have no pain-induced reorganizational changes 
in the central nervous systems. In the neurophysiological investigation, we adopted information 
derived from occipital EEG alpha rhythms to quantitatively evaluate thalamic activity. EEG studies 
have a merit for investigating psychological aspects, such as pain or pain-related unpleasantness, 
compared with conventional studies with functional magnetic resonance imaging (fMRI) 
measurements, which could be stressful for subjects. A long history correlates with EEG alpha rhythms. 
Studies utilizing neuroimaging techniques revealed central neural correlates including the thalamus, 
which particularly attracted much interest because the results indicated that surface EEG reflects deep 
brain network (DBN) activities. Although whether the correlation is positive [50–52] or negative [53, 
54] has been a matter of argument in published papers, a recent report [55, 56] concluded this issue 
through its findings that neural correlates with occipital EEG alpha rhythms depend on the frequencies 
of alpha rhythm power fluctuations. This report also gives the best suggestion that a region of the 
thalamus, associated with the brain stem and anterior cingulate cortex, is positively correlated with the 
slow fluctuation components of the alpha rhythm power. These neural parts related to the positive 
correlation are considered to form DBN. Hence, the evaluated slow components reflect DBN activity. 
We consider that this DBN activity corresponds to the thalamic activity evaluated by neuroimaging as 
mentioned above, because blood oxygenation level-dependent (BOLD) signals do not reflect any 
information related to the fast modulation components of the EEG alpha-2 rhythm powers.  
 
0DWHULDOVDQG0HWKRGRORJ\
6XEMHFWV 
Thirteen healthy Japanese volunteers including 10 females and 3 males (age, mean ± SD: 21.2 ± 1.36 
years) were enrolled in this study. We did not take the sex differences into account in this study. All of 
them provided written informed consent. We carefully checked their health conditions according to 
the medical history declared by themselves to eliminate participants having diseases such as a liver 
disease, kidney disease, neuropathy, heart disease, or even chronic pain. We also determined whether 
the participants were allergic to Yuzu essential oil using the conventional patch test. Table 1 shows 
the characteristics of the subjects. 
This study was approved by the Ethics Committees of Graduate School of Health Sciences of Kobe 
University, the Nursing Department of Aichi Medical University, and the National Institute of 
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Communication Technology.  
7DEOH6XEMHFW&KDUDFWHULVWLFV

Thirteen healthy Japanese volunteers including 10 females and 3 males were enrolled in the study. We first 
examined how temperament scale scores (State– Trait Anxiety Inventory-form JYZ: STAI-form JYZ, 
Global Scale for Depression: GSD) affect pain ratings. We show below the total score with both scales. 
Moreover, questions regarding the presence or absence of pain as well as stress-associated with pain were 
included.  

0HWKRGRORJ\
&KURQLFSDLQVWLPXOLE\FROGSUHVVRUWDVN
To experimentally simulate chronic pain, we used a cold pressor task (CPT) [57] scheme in which 
subjects are asked to immerse their hands in cold water. The temperature of the water was maintained 
at 10–11°C using an electrical cooling device, and this low temperature activates afferent C-fibers via 
TRPA1 receptors [58]. The duration of immersion was approximately a few minutes to eliminate the 
influence of acute pain sensation signals transmitted along the spinothalamic tract. 
The C-fibers play a primary role in the neural systems for chronic pain perception, therefore, it is 
assumed that the CPT scheme can temporarily generate chronic or pseudo-chronic pain.  
 
(VVHQWLDORLO  
We used Yuzu (&LWUXV-XQRV) oil, Yuzu in Japanese, for experiments preformed in the present study. 
This oil has been welcomed by many Japanese who associate it with pleasant feelings. It has also been 
traditionally used in Japan as a popular health- maintenance remedy. Such benefits of the oil will be 
advantageous for making aroma touch therapy more popular in hospices or nursing homes. Taking 
into account the results of our advanced clinical trial as mentioned above, Yuzu oils with the same 
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components as those used in the trial were employed in the present study. Yuzu peels (products of 
Kochi Prefecture, Japan) were squeezed by steam distillation under a decompression condition [59], 
and the wastes obtained were used for preparing Yuzu essential oil with sesame oil (6HVDPXPLQGLFXP; 
Musee Inc., Osaka, Japan). The prepared Yuzu oil consisted of linalool (70.89%), alpha-terpineol 
(13.13%), thymol (6.38%), limonene (4.94%), and 4-terpineol (4.66%). The carry-over effects of the 
Yuzu oil was examined in advance, and throughout the examination, we did not observe any serious 
side effects for any subject.  
 
7RXFKDQGDURPDWRXFKWKHUDS\
Our touch therapy was based on the superficial effleurage scheme [60, 61] applied from fingers to an 
elbow with a stroke velocity in the range from 3 to 5 cm/s. The control touch therapy used in the study 
was performed according to the above procedure using a non-essential oil such as sesame oil. This 
scheme was followed in aroma touch therapy; however, the Yuzu essential oil was used instead of the 
sesame oil.  

7HPSHUDPHQWHYDOXDWLRQ
Subjective temperaments were evaluated using the State–Trait Anxiety Inventory (STAI)-form JYZ, 
modified from STAI form-Y proposed by Spielberger [62], and Global Scale for Depression (GSD) 
[63]. According to the STAI-JYZ criteria, scores in the range of 20–80 are related to specific 
psychiatric dysfunctions such as state anxiety or trait anxiety. A score of 55 is considered high-level 
anxiety, and a score of <45 is considered low-level anxiety [64]. On the basis of the GSD criteria, 
depression can be objectively diagnosed according to the scores, i.e., as mild (30–36), moderate (37–
43), and serious (44) [63].  
 
2EMHFWLYHHYDOXDWLRQRIHPRWLRQDOUHVSRQVHV
Transient emotional responses to pain were objectively evaluated using subjective reports to reveal 
the relationship between emotion and pain ratings. The objective evaluation was based on 
psychological scales including valence varying from pleasant to unpleasant, arousal varying from 
awaking to sleepiness, stability varying from sedation to agitation [65], vitality varying from positive 
to negative (fatigue), and preference to odors. A psychiatric scale related to depression or anxiety was 
also used to evaluate the specific emotional states of subjects under chronic pain. All scales were 
objectively evaluated using the Visual Analog Scale (VAS) that ranged from 0 to 100 mm, and the 
VAS scores generated are sufficiently reliable for statistical analyses [66].  
 
3DLQUDWLQJVDQGFODVVLILFDWLRQ
Pain ratings were objectively evaluated using the Numerical Rating Scale (NRS), which has been widely 
used in clinical practice [67]. The NRS scores ranged from 0 to 10, and these scores are assigned according 
to the declaration made by the subjects on the basis of their sensitivity to pain. These NRS scores are 
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sufficiently reliable for statistical analyses.  
 
((*UHFRUGLQJVDQGGDWDSURFHVVLQJ
EEG recordings were performed using 21 Ag/AgCl electrodes placed according to the International 
10-20 system (sampling frequency: 512 Hz, resolution: 24 bit). EEG signals were analyzed using a 
fast Fourier transform (FFT) technique to generate time-series data of occipital (O1, O2) alpha-2 band 
(10–13 Hz) powers extracted from the FFT data [rate: 32-SPS (samples/s), epoch: 1 s]. The DBN 
activity index was defined as slow fluctuation components of the time-series data calculated by a 
moving-average technique.  
 
+HPRHQFHSKDORJUDPUHFRUGLQJV
As the frontal lobe is activated by pain or other unpleasant stimuli [68], we can support objective pain 
ratings according to a subjective declaration.  
Hence, regional central blood flows at the center of a patient’s forehead were measured using a 
near-infrared hemoencephalogram (NIR-HEG) sensor. This measurement scheme provides a simple 
and convenient method for evaluating the dynamic responses of regional brain activities, which can 
be calculated from relative oxygenated hemoglobin and deoxyhemoglobin concentrations.  
 
([SHULPHQWDOSURWRFRO 
In a familiarization session, subjects who provided written informed consent were interviewed to know 
their medical history and tested not to have any allergy to essential oils used in the study. Experiments 
were performed with subjects who had cleared this allergy test. The experimental protocol is shown 
in Fig. 1. For the experiment, subjects were seated upright in a comfortable chair with their eyes closed. 
EEG and NIR-HEG measurements were performed continuously throughout the protocol. The 
protocol consisted of three major sessions: a rest session for measuring baseline neural activities, a 
therapy session, and a pain evaluation session. The duration of each of these sessions was 5 min. In 
the therapy session, touch or aroma touch therapy were applied to one hand of the subjects. In the pain 
evaluation session, painful stimuli through CPT were applied to the other hand of the subjects while 
the therapies were continued. Pain evaluation was performed under the three conditions: a baseline 
condition without any therapies, a control condition using sesame oil as a non-essential oil, and an 
aroma touch condition using touch with the Yuzu essential oil. The subjects were asked to declare 
their pain at every 30 s, and scores were accordingly assigned in the range of 0–10. A cross-task design 
was adopted to eliminate cross correlation between the control and aroma touch conditions.  

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)LJXUH7KH6WXG\3URWRFRO 
A cross-task design was adopted to eliminate the influences of the carry-over effects of essential oil. 
Subjects were interviewed to clarify their temperament using Global Scale for Depression (GSD) and State–
Trait Anxiety Inventory form-JYZ (STAI). Then, they were required to undergo three cold pressor task 
(CPT) exposures under different conditions: baseline (the baseline condition with no therapy), control 
[touch with placebo (sesame oil)], and aroma touch. Pain ratings were evaluated using Numerical Rating 
Scale (NRS) at every 30 s during CPT. Psychological evaluations for emotional responses using Visual 
Analogy Scale (VAS) were performed in the rest durations. In the entire experimental period, spontaneous 
electroencephalogram (EEG) and near-infrared hemoencephalogram (NIR-HEG) were recorded. 


6WDWLVWLFDODQDO\VLV 
To discuss statistical significance, we adopted paired t-test. The significance level was set at 0.05. 
Calculations were performed using SPSS 20.0. To discuss statistical dependence, we used Spearman’s 
rank correlation coefficient and Pearson’s correlation coefficients. Significance was based on the 
critical value table where critical correlation coefficients to satisfy the significance level of 0.05 are 
given for each sample size.  
 
 
5HVXOWV
6XEMHFWLYHUDWLQJVRIFKURQLFSDLQ
Grand-averaged subjective dynamic responses to pain are shown in Fig. 2(a) for the three procedural 
conditions (baseline, control, and aroma touch). In all of the responses, the pain ratings similarly 
exhibited an increase to a peak within a few minutes, and then a gradual decrease. However, pain relief 
dominance was maintained during the entire period under the painful stimuli such that the aroma touch 
condition was the first, the control condition was the second, and the baseline condition was the third. 
Such dynamic responses were characterized by their maximum and final pain ratings, which were 
statistically analyzed (Fig. 2b). Results show that the pain-relief effects of the aroma touch condition 
were always superior to those of the baseline condition in both maximum and final pain ratings (3< 
0.01). The control condition also exhibited similar superiority in pain relief to the baseline condition 
(3 < 0.05) in both maximum and final pain ratings. However, it did not exhibit any significant 
difference in the pain-relief effects compared with the aroma touch condition.  
   Because grand averages may cancel the subject-dependent specific aspects of the dynamic 
responses to pain, we categorized the subjects into three groups according to the final pain ratings: a 
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strong pain relief group exhibiting final pain ratings of 0–1, a moderate pain relief group with final 
pain ratings of 2–4, and a mild a pain relief group with final pain ratings of 5–6. The data 
corresponding to the final pain ratings >7 were not considered for this categorization. Such 
classification schemes according to pain ratings are considered useful for clinical practices including 
symptom assessment [69]. 
 
㻜 㻝 㻞 㻟 㻠 㻡
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻼㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㼟㻌㼛
㼚㻌㻺
㻾㻿
㻌㻔㻜
㻙㻝
㻜㻕
㻵㼙㼙㼑㼞㼟㼕㼛㼚㻌㼠㼕㼙㼑㻌㻔㼙㼕㼚㻕
㻌㻮㼍㼟㼑㼘㼕㼚㼑
㻌㻯㼛㼚㼠㼞㼛㼘
㻌㻭㼞㼛㼙㼍㻌㼠㼛㼡㼏㼔
 㻮㼍㼟㼑㼘㼕㼚㼑 㻯㼛㼚㼠㼞㼛㼘 㻭㼞㼛㼙㼍㻌㼠㼛㼡㼏㼔
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻼㻌㻨㻌㻜㻚㻜㻝
㻼㻌㻨㻌㻜㻚㻜㻡
㻹㼍
㼤㼕㼙
㼡㼙
㻌㼜㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㻌㻔㻜
㻙㻝
㻜㻕
 㻮㼍㼟㼑㼘㼕㼚㼑 㻯㼛㼚㼠㼞㼛㼘 㻭㼞㼛㼙㼍䚷㼠㼛㼡㼏㼔
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻼㻌㻨㻌㻜㻚㻜㻡
㻼㻌㻨㻌㻜㻚㻜㻝
㻲㼕㼚
㼍㼘㻌
㼜㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㼟㻌㻔
㻜㻙
㻝㻜
㻕

D (E
㻜 㻝 㻞 㻟 㻠 㻡
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻵㼙㼙㼑㼞㼟㼕㼛㼚㻌㼠㼕㼙㼑㻌㻔㼙㼕㼚㻕
㻌㻿㼠㼞㼛㼚㼓㻌㼜㼍㼕㼚㻌㼞㼑㼘㼕㼑㼒㻌㼓㼞㼛㼡㼜
㻌㻹㼛㼐㼑㼞㼍㼠㼑㻌㼜㼍㼕㼚㻌㼞㼑㼘㼕㼑㼒㻌㼓㼞㼛㼡㼜
㻌㻹㼕㼘㼐㻌㼜㼍㼕㼚㻌㼞㼑㼘㼕㼑㼒㻌㼓㼞㼛㼡㼜
㻼㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㼟㻌㼛
㼚㻌㻺
㻾㻿
㻌㻔㻜
㻙㻝
㻜㻕 㻮㼍㼟㼑㼘㼕㼚㼑
㻜 㻝 㻞 㻟 㻠 㻡
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻼㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㼟㻌㼛
㼚㻌㻺
㻾㻿
㻔㻜㻙
㻝㻜
㻕
㻯㼛㼚㼠㼞㼛㼘
㻵㼙㼙㼑㼞㼟㼕㼛㼚㻌㼠㼕㼙㼑㻌㻔㼙㼕㼚㻕 㻜 㻝 㻞 㻟 㻠 㻡
㻜
㻞
㻠
㻢
㻤
㻝㻜
㻼㼍
㼕㼚㻌
㼞㼍㼠
㼕㼚㼓
㼟㻌㼛
㼚㻌㻺
㻾㻿
㻌㻔㻜
㻙㻝
㻜㻕
㻵㼙㼙㼑㼞㼟㼕㼛㼚㻌㼠㼕㼙㼑㻌㻔㼙㼕㼚㻕
㻭㼞㼛㼙㼍㻌㼠㼛㼡㼏㼔
 
F 
)LJXUH*HQHUDODVSHFWVRIFKDQJHVLQSDLQUDWLQJGXULQJFROGSUHVVRUWDVN&37XQGHUWKH
WKUHHSURFHGXUDOFRQGLWLRQVRIWKHEDVHOLQHFRQWURODQGDURPDWRXFK 
Pain ratings were numerically evaluated using the numerical rating scale (NRS), which ranged from 0 to 
10, and these scores are assigned according to the declaration made by the subjects. (a) Grand-averaged 
temporal changes in pain ratings (mean ± standard error). (b) Test of significance in pain-relief effects for 
the three procedural conditions evaluated using maximum and final pain rating scores in the temporal 
changes in pain rating (paired t-test). (c) Individual evaluations of temporal changes in pain rating during 
CPT duration for the three groups: a strong pain relief group (final pain ratings in a range of 0 - 2), a 
moderate pain relief group (3 - 4), and mild pain relief group (5 - 6). Data of a group with pain ratings of 
>7 were not used for this evaluation because the group did not show any pain-relief effects compared with 
their initial pain ratings when CPT began (mean ± standard error). 
 
 
For each of the procedural conditions, dynamic responses to pain were exhibited for the three 
groups, as shown in Fig. 2(c). Independently of the procedural conditions, the moderate and mild pain 
relief groups represented a response pattern similar to that for the grand averages. In contrast, the 
strong pain relief group exhibited extreme pain-relief effects according to the pain relief dominance 
as described above. 
9 
 
 
   In the strong pain relief group, we found the analgesic effects of aroma touch in some subjects. 
These effects not only reduced maximal pain ratings but also provided complete pain-free states (NRS 
= 0) at the end of CPT (Fig. 3).  

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)LJXUH  7HPSRUDO FKDQJHV LQ SDLQ UDWLQJ H[KLELWHG E\ DQ H[WUDRUGLQDU\ FDVH WKDW GHYHORSHG
FRPSOHWHSDLQIUHHVWDWHVDQDOJHVLDLQWKHILQDOVWDJHRIWKHFROGSUHVVRUWDVN
Pain ratings under the three conditions in a subject from the strong pain relief group. 
 
&RUUHODWLRQRISDLQUDWLQJVZLWKWHPSHUDPHQWDQGHPRWLRQDOUHVSRQVHVWRSDLQ
We first examined how temperament scale scores affect pain ratings. The maximum and final pain 
ratings versus GSD total scores are shown in Fig. 4(a) for the three procedural conditions. For the 
aroma touch condition, a negative correlation was observed between the GSD total scores and 
maximum pain ratings (UV= í0.65, 3< 0.05) as well as between the GSD total scores and final ratings 
(UV= í0.58, 3< 0.05) (Fig. 4(a)).  
We also examined how anxiety scale scores affect pain ratings. While no correlation was observed 
between the trait anxiety and pain ratings, a negative correlation was observed between the state 
anxiety and maximum pain ratings (UV = í0.72, 3 < 0.01) only for the control condition and a negative 
correlation was observed between the state anxiety and final pain ratings (UV= í0.55, 3 = 0.52) (Fig. 
4(b)). 
   Consequently, these temperamental factors exhibited a tendency to provide high pain-relief effects 
for those who had lower averaged DBN indices, while statistical significance was completely obtained 
for all the factors. 
   We furthermore investigated emotional responses to pain. Figure 5 shows a series of emotional 
scale scores for the different pain relief groups. The scores were compared among the three procedural 
conditions. In the strong pain relief group, aroma touch seemed to induce emotional states to the 
condition specified by “pleasant” for the valence scale, “awaking” for the arousal scale, and “sedation” 
for the stability scale. In contrast, in the mild pain relief group, aroma touch seemed to induce “sedation” 
and “sleepiness.” These emotional responses to pain did not reach any statistical significance.  
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The maximum and final pain ratings under the three conditions (baseline, control, and aroma touch) 
examined the correlation between the Global Scale for Depression (GSD) total score and the state anxiety 
total score (Spearman’s rank correlation coefficient). (a) Correlation between GSD and the pain, (b) 
Correlation between the state anxiety of State–Trait Anxiety Inventory (STAI)-form JYZ and the pain.
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)LJXUH(YDOXDWLRQRIHPRWLRQDODQGWHPSHUDPHQWVWDWHVGXULQJWKHFROGSUHVVRUWDVNIRUWKHWKUHH
VXEMHFWJURXSV
The graphs display a strong pain relief group (final pain ratings of 0 - 2), a moderate pain relief group (3 - 
4), and a mild pain relief group (5 - 6). The emotional states were evaluated using three emotional scales, 
including valence (from pleasant to unpleasant), arousal (from awaking to sleepiness), and stability (from 
sedation to agitation), and two temperament scales related to depression and fatigue. No significance was 
observed was between the emotional/temperament scales and procedural conditions.


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2FFLSLWDO((*DOSKDSRZHUUHVSRQVHVWRFKURQLFSDLQVWLPXOL
In a typical dynamic response to chronic pain imposed by the painful stimuli administered in CPT, the 
occipital EEG alpha-2 power as a DBN activity index exhibited a transient sharp increase to a peak 
within a few minutes after CPT began, and then a prompt decrease, as shown in Fig. 6.  
To objectively evaluate the correlation between pain-relief effects and DBN activity, we adopted 
an average DBN activity index, which is defined as an overall DBN activity derived from the occipital 
EEG alpha-2 powers processed by the moving average technique during the 5-min CPT. Figure 7 
shows the maximum and final pain ratings as a function of the average DBN activity index. In each of 
these two cases, we found extraordinary correlations exhibiting a V-shaped curve in the 
maximum/final pain ratings versus the average DBN activity index. Such correlations were attributed 
to the fact that the effects of chronic pain relief were positively correlated with DBN activity in the 
regions with lower DBN activities, whereas the effects were negatively correlated with DBN activity 
in the regions with higher DBN activities. These correlations provided higher absolute correlation 
coefficients (U > 0.8) with significance (3< 0.001) particularly for the final pain ratings.  

)LJXUH$W\SLFDOG\QDPLFUHVSRQVHRIWKHRFFLSLWDO((*DOSKD±+]UK\WKPSRZHUVXQGHU
WKHPLQ&37SDLQIXO6WLPXOL 
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)LJXUH  '%1 DFWLYLW\ HYDOXDWHG E\ RFFLSLWDO ((* DOSKD UK\WKP SRZHUV YHUVXV SDLQ UHOLHI
SHUIRUPDQFHVHYDOXDWHGE\PD[LPXPDQGILQDOSDLQUDWLQJVGXULQJWKHFROGSUHVVRUWDVN 
This figure shows the maximum and final pain ratings as a function of the average DBN activity index. 
Data from all subjects were superposed in the graphs, in which strong negative and positive correlations 
were found (Pearson’s correlation coefficients). The arrow shows the movement toward the direction that 
was believed to be the personal equivalent point. 
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  1HXURSK\VLRORJLFDO HYDOXDWLRQ RI D FRPSOHWH SDLQIUHH VWDWH LQGXFHG E\ DURPD WRXFK
WKHUDS\
We found that a complete pain-free state can be obtained by aroma touch therapy, as shown in Fig. 3. 
We here measured neurophysiological responses under such an analgesic state. Figure 8 shows the 
dynamic responses of DBN activity evaluated by occipital EEG alpha-2 rhythm powers and the 
corresponding regional blood flows at the center of a subject’s forehead evaluated by NIR-HEG for 
the three procedural conditions. For both the baseline and control conditions, DBN activity remained 
lower, while NIR-HEG responses exhibited an increase and remained higher after CPT began. Such 
NIR-HEG responses indicated that the subjects surely felt pain. In contrast, for the aroma touch 
condition, DBN activity exhibited an extreme increase and the corresponding NIR-HEG responses 
exhibited a significant decrease. The lower NIR-HEG confirmed that the subjects did not feel any pain.  

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)LJXUH'\QDPLFUHVSRQVHVRI'%1DFWLYLW\HYDOXDWHGE\RFFLSLWDO((*DOSKDUK\WKPSRZHUVDQG
FRUUHVSRQGLQJUHJLRQDOEORRG IORZVHYDOXDWHGE\1HDULQIUDUHG+HPRHQFHSKDORJUDP1,5+(*
VLJQDOVGXULQJWKHFROGSUHVVRUWDVN&37 
The X-axis represents time in min, the closed bar on the X-axis indicates the duration of CPT, and 0 min 
indicates the starting point of CPT. 
 
 
'LVFXVVLRQ
We investigated the pain-relief effects of aroma touch therapy with &LWUXVMXQRV oil for cold pressure-
induced chronic pain. We found a strong correlation between the pain-relief effects and DBN activity 
that was estimated by occipital EEG alpha-2 rhythm powers independently of emotional changes. We 
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also found that aroma touch therapy optimally modulates DBN activity to obtain maximal analgesic 
effects.  
 
+RZ'%1DFWLYLW\LVFKDQJHGE\WKHSDLQUHOLHIHIIHFWVRIDURPDWRXFKWKHUDS\"
The results of the positive correlation between the pain ratings and the DBN activity index agreed with 
the prediction by the previous studies on activation of the thalamus for chronic pain relief. However, 
the negative correlation was not expected based on the hypothesis. Many factors may contribute to 
providing such characteristics of the correlation. A promising factor is the dual pathway for 
transmitting signals of chronic pain. Nociceptive pain stimuli may activate an acute pain pathway 
related to the spinothalamic tract well as a dull pain pathway related to thalamic intralaminar nuclei. 
The former deteriorates pain-relief effects, while the latter alleviates chronic pain sensations, as we 
expect. The total pain ratings evaluated by the sum of the two pain sensations represents such V-shaped 
curves. 
We also found that aroma touch therapy did not always increase DBN activity. This means that 
DBN activity was increased in the region with lower DBN activity, while it was decreased in the region 
with higher DBN activity. However, pain ratings were always decreased along the V-shaped curve by 
aroma touch therapy. Although such DBN behaviors may be explained on the basis of the balance of 
monoaminergic systems, the true mechanism must be clarified in future studies.  
 
:KLFKLVGRPLQDQW'%1DFWLYLW\RUHPRWLRQDOHIIHFWVLQFKURQLFSDLQUHOLHI"
While correlations between emotional responses and pain ratings were consistent for the three 
procedural conditions (baseline, control, and aroma touch), strong correlations between DBN activity 
and pain ratings, exhibiting a V-shaped curve, were observed. These findings indicate that DBN 
activity is dominant for chronic pain relief independently of emotional responses. Emotional responses 
changing to “pleasant” and “awaking” are non-essential for pain relief and are merely associated with 
increasing DBN activity.  
 
 
/LPLWDWLRQV
The study sample was small and lacked homogeneity of subjects. Notwithstanding these limitations, 
the neural mechanism of chronic pain relief based on DBN activity, as indicated by the findings, will 
be essential for predicting subject-dependent pain relief performances. Further studies of such 
mechanisms should aim to determine methods to relieve chronic pain in cancer patients.  
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&RQFOXVLRQ
We investigated the analgesic effects of aroma touch therapy. We found that the pain-relief effects are 
strongly correlated with DBN activity, evaluated on the basis of the slow fluctuation components of 
occipital EEG alpha-2 (10–13 Hz) powers independently of emotional changes. We found that the 
correlation exhibits a V-shaped curve; the pain ratings decrease with increasing DBN activity in the 
region with lower DBN activity, while they increase with decrease in DBN activity in the region with 
higher DBN activity. We also found that the V-shaped curve provides an optimum condition that can 
induce complete pain-free states. 
Notwithstanding that neural mechanisms must be elicited for explaining such strong correlation 
between DBN activity and the pain-relief effects, objective evaluation schemes using the DBN activity 
will be a powerful tool for investigating a wide variety of clinical effects of aroma or aroma touch 
therapies.  
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